Our Members

As a member-focused Association, our members are at the heart of everything we do at the PRI.

In principle any organization (public or private) is eligible to join the Association and become part of Europe’s growing microbiome-based medicinal product ecosystem.

Find out more about the different ways you and your organization can get involved with the PRI’s activities.

  • Microbiome Regulatory Science Support Work
  • Pre-competitive Task Groups
  • Year-round networking and project-related communication support

More than 100 PRI Members from 24 countries represent nearly every point along the microbiome science and development continuum, from fundamental research groups all the way to commercial manufacturing partners and pharmaceutical companies.

BIOASTER

BIOASTER

Vincent Thomas

Head of the Microbiome Program

Established in 2012, BIOASTER is a private, non-profit Foundation that works to develop innovative technologies to support the latest challenges in microbiology research.

 

Biofortis

Biofortis

Benoît Fouchaq

CEO

Biofortis is a unique full services CRO providing Nutrition Clinical Trials, Microbiome Investigation and Data Science for Human and Animal Health.

 

Biogaia

Biogaia

Isabelle Ducellier

CEO

leading global probiotics company

 

Biomeostasis

Biomeostasis

Bruno Bariohay

CEO

BIOMEOSTASIS provides preclinical in vivo pharmacology services in the field of metabolic, GI and aged-related disorders.

 

Biomica

Biomica

Elran Haber

CEO

Biomica is an emerging biopharmaceutical company developing innovative microbiome-based therapeutics for the treatment of immune-mediated and infectious diseases, with specific focus on Immuno-Oncology and GI related disorders.

 

Biose Industrie

Biose Industrie

Richard Ellis

Business Development

Founded in 1951 by pharmacists and microbiologists, biose® industrie has 70-years experience in drugs based on live bacteria, giving us a deep understanding of the entire process from discovery to commercialization. Focused on Health through microbiota and microbiome science, we use our skills for the discovery, product development, clinical studies and manufacturing of Live Biotherapeutic Products (LBP). Our company is drug-GMP certified for the manufacturing of bacteria-based Drug Substance and Drug Product for clinical and commercial applications.

 

Boehringer Ingelheim

Boehringer Ingelheim

Anne Cadoux

Head of Regulatory Affairs Animal Health Care Products

Boehringer Ingelheim Animal Health France is born from Merial in 2018 further to the acquisition of Merial by Boehringer Ingelheim, a large pharmaceutical company with a small Animal Health department. Now 2nd biggest company in the world for Animal Health products. Innovation is one of its characteristics.

 

BoobyBiome

BoobyBiome

Lydia Mapstone

Co-Founder & CEO

BoobyBiome, a female-led UK-micro SME, is developing a rationally-designed live biotherapeutic product (LBP) tailored for babies with compromised microbiomes. Informed by rigorous scientific testing and precise characterisation of breast milk, the LBP will replenish the infant gut to a healthier state.